# AI for CRISPR

<img src="./images/crispr_tasks.jpg" style="width: 700px">

*Categorization of CRISPR related applications/tasks ([Abbasi et al., 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC11796103/)*)

–ü–æ–¥—Ä–æ–±–Ω—ã–π –æ–±–∑–æ—Ä –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ò–ò –≤ CRISPR-—Å–≤—è–∑–∞–Ω–Ω—ã—Ö –∑–∞–¥–∞—á–∞—Ö –ø—Ä–∏–≤–µ–¥–µ–Ω –≤ —Å—Ç–∞—Ç—å–µ [A. F. Abbasi et al. (2025) Transitioning from wet lab to artificial intelligence: a systematic review of AI predictors in CRISPR](https://pmc.ncbi.nlm.nih.gov/articles/PMC11796103/). –í [–¢–∞–±–ª–∏—Ü–µ 18](https://pmc.ncbi.nlm.nih.gov/articles/PMC11796103/table/Tab18/) –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã performance values of 39 different predictors across 76 different benchmark datasets related to 10 different CRISPR tasks

# LLM for CRISPR

## CRISPR-GPT

[K. Huang et al. (2024) CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments](https://arxiv.org/pdf/2404.18021)

The innovation of CRISPR-GPT Agent allows automated designs of gene-editing experiments
by simplifies the complex process into a series of manageable steps:
- Selection of CRISPR System: Tailoring the choice of CRISPR system to the experiment‚Äôs
needs.
- gRNA Design: Optimizing guide RNA sequences for efficiency and specificity based on the
Broad Institute‚Äôs gold-standard guideRNA library and CRISPRPick toolkit, including predesigned gRNA libraries [28, 14, 15, 43].
- Delivery Approach Selection: Advising on the most effective methods to introduce the CRISPR
components into target cells.
- Prediction of Off-target Effects: Assessing potential unintended alterations alongside desired
edits.
- Recommendation of Experimental Protocols: Outlining step-by-step procedures tailored to
the experiment‚Äôs objectives.
_ Validation Approach Recommendation and Primer Design: Recommending gest ways to validate the edits and help design the associated primers.

This approach, leveraging a chain-of-thought reasoning model and state machines, ensures that
even individuals new to gene editing can iteratively refine their experimental designs to achieve
protocols that meet their specific research needs. In addition, CRISPR-GPT offers:
- A Freestyle Q&A Mode for addressing ad hoc queries with precision,
- An Off-target Prediction Mode for in-depth analysis of pre-designed gRNAs.
These functions help the users when they meet additional issues during the experimental design
process.

![CRISPR-GPT evaluation results](/images/crispr_gpt_scores.png)
*Evaluation results showing comparative performance of CRISPR-GPT and ChatGPT 3.5/4.0 in a range of gene-editing experiment design tasks across three different modes: MetaMode, AutoMode and QAMode. All tasks are scored in four different aspects: accuracy, reasoning, completeness, and conciseness. A score of 1 represents poor performance and 5 represents excellent performance.* *([Huang et al., 2024](https://arxiv.org/pdf/2404.18021))*

## ProGen2 and ESM-2

[J. Ruffolo et al. (2024) Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences](https://www.biorxiv.org/content/10.1101/2024.04.22.590591v1.full.pdf)

–ö—Ä–∞—Ç–∫–∏–π –æ–±–∑–æ—Ä —Å—Ç–∞—Ç—å–∏ –Ω–∞ —Ä—É—Å—Å–∫–æ–º: [–°–æ–∑–¥–∞–Ω–Ω–∞—è –Ω–µ–π—Ä–æ—Å–µ—Ç—å—é —Å–∏—Å—Ç–µ–º–∞ CRISPR-Cas9 –æ—Ç—Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–ª–∞ –≥–µ–Ω–æ–º —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏—Ö –∫–ª–µ—Ç–æ–∫ | N+1](https://nplus1.ru/news/2024/04/25/neurocrisprhttps://nplus1.ru/news/2024/04/25/neurocrispr)

While these novel systems have been sought for specific properties, such as small size or extended protein stability in biofluids (1, 2), they typically exhibit trade-offs in critical attributes such as basal activity in target cells, PAM selectivity, thermal optima, or in vitro biochemical properties, ultimately limiting their reach

–í –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –≥–µ–Ω–µ—Ä–∏—Ä—É—é—Ç—Å—è –Ω–æ–≤—ã–µ –≤–µ—Ä—Å–∏–∏ –Ω—É–∫–ª–µ–∞–∑ (–±–µ–ª–∫–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö —Ä–∞–∑—Ä–µ–∑–∞—Ç—å –î–ù–ö), –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–µ –¥–ª—è —Ä–∞–±–æ—Ç—ã –≤ —Å–∏—Å—Ç–µ–º–µ CRISPR-Cas. –≠—Ç–∏ –Ω—É–∫–ª–µ–∞–∑—ã, –Ω–∞–ø—Ä–∏–º–µ—Ä, –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–µ Cas9, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω—ã –¥–ª—è —É–ª—É—á—à–µ–Ω–Ω–æ–π —Ä–∞–±–æ—Ç—ã –≤ —Å–∏—Å—Ç–µ–º–∞—Ö —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–º–∞, —Ç–∞–∫–∏—Ö –∫–∞–∫ CRISPR-Cas, –Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω–æ–π —Ç–æ—á–Ω–æ—Å—Ç—å—é –∏ —Å–Ω–∏–∂–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º off-target —ç—Ñ—Ñ–µ–∫—Ç–æ–≤.

–ê–≤—Ç–æ—Ä—ã –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–ª–∏ –±–æ–ª—å—à—É—é —è–∑—ã–∫–æ–≤—É—é –º–æ–¥–µ–ª—å (LLM) ProGen2, —Å–æ–∑–¥–∞–Ω–Ω—É—é –∏–º–∏ —Ä–∞–Ω–µ–µ –¥–ª—è –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–≤–æ–≥–æ –¥–∏–∑–∞–π–Ω–∞ –±–µ–ª–∫–æ–≤—ã—Ö –º–æ–ª–µ–∫—É–ª. –¶–µ–ª—å—é –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –±—ã–ª–æ —Å–æ–∑–¥–∞—Ç—å –Ω–æ–≤—ã–µ –±–µ–ª–∫–∏ —Å —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ—Å—Ç—å—é, —Å—Ö–æ–∂–µ–π —Å Cas9, –Ω–æ —Å –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–π —Å–ø–µ—Ü–∏—Ñ–∏—á–Ω–æ—Å—Ç—å—é –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é –≤ —É—Å–ª–æ–≤–∏—è—Ö —á–µ–ª–æ–≤–µ–∫–∞. –ù–∞–ø—Ä–∏–º–µ—Ä, –æ–Ω–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –±–µ–ª–æ–∫ OpenCRISPR-1, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∫–∞–∑–∞–ª –≤—ã—Å–æ–∫—É—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–∏ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏–∏ –≥–µ–Ω–æ–º–∞ –≤ —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏—Ö –∫–ª–µ—Ç–∫–∞—Ö –∏ –∏–º–µ–ª –º–µ–Ω—å—à–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ off-target —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –Ω—É–∫–ª–µ–∞–∑–æ–π SpCas9.

![–ì–µ–Ω–µ—Ä–∏—Ä–æ–≤–∞–Ω–∏–µ —Ä–∞–∑–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ CRISPR-Cas](/images/opencrispr1.jpg)
*–ì–µ–Ω–µ—Ä–∏—Ä–æ–≤–∞–Ω–∏–µ —Ä–∞–∑–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ CRISPR-Cas*

–°—Ç–∞—Ç—å—è –ø—Ä–æ ProGen-2: [E. Nijkamp et. al. (2023) ProGen2: Exploring the boundaries of protein language models](https://www.cell.com/action/showPdf?pii=S2405-4712%2823%2900272-7)

## CRISPR-BERT

[Y. Luo et al. (2024) Interpretable CRISPR/Cas9 off-target activities with mismatches and indels prediction using BERT](https://www.sciencedirect.com/science/article/pii/S0010482524000167)

1. –î–ù–ö-–ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∫–æ–¥–∏—Ä—É—é—Ç—Å—è –≤ –≤–∏–¥–µ —Ç–æ–∫–µ–Ω–æ–≤ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å–ª–æ–≤–∞—Ä—è (–≥–¥–µ –∫–∞–∂–¥—ã–π –Ω—É–∫–ª–µ–æ—Ç–∏–¥ –∏–ª–∏ –∫–æ–º–±–∏–Ω–∞—Ü–∏—è —Å indel'–∞–º–∏ –∏–º–µ–µ—Ç —á–∏—Å–ª–æ–≤–æ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏–µ).
2. *–≠—Ç–∏ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –æ–±—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç—Å—è BERT, –∫–æ—Ç–æ—Ä—ã–π –∏–∑–≤–ª–µ–∫–∞–µ—Ç –∫–æ–Ω—Ç–µ–∫—Å—Ç–Ω—ã–µ –ø—Ä–∏–∑–Ω–∞–∫–∏ (–≤–∞–∂–Ω—ã–µ —É—á–∞—Å—Ç–∫–∏, –ø–∞—Ç—Ç–µ—Ä–Ω—ã –º—É—Ç–∞—Ü–∏–π).*
3. –í—ã—Ö–æ–¥–Ω—ã–µ –ø—Ä–∏–∑–Ω–∞–∫–∏ –∏–∑ BERT –∫–æ–º–±–∏–Ω–∏—Ä—É—é—Ç—Å—è —Å CNN –∏ BiGRU, —á—Ç–æ–±—ã —É—á–µ—Å—Ç—å –∫–∞–∫ –ª–æ–∫–∞–ª—å–Ω—ã–µ, —Ç–∞–∫ –∏ –¥–ª–∏–Ω–Ω—ã–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –≤ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—è—Ö.
4. –î–æ–±–∞–≤–ª—è–µ—Ç—Å—è –±–∞–ª–∞–Ω—Å–∏—Ä–æ–≤–∫–∞ –∫–ª–∞—Å—Å–æ–≤, —á—Ç–æ–±—ã —É–ª—É—á—à–∏—Ç—å —Ä–∞–±–æ—Ç—É –º–æ–¥–µ–ª–∏ –Ω–∞ –Ω–µ—Ä–∞–≤–Ω–æ–º–µ—Ä–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö.

## RNA-FM (as part of DeepFM-Crispr)

–í —Å—Ç–∞—Ç—å–µ *[C. Bao, F. Liu (2024) DeepFM-Crispr: Prediction of CRISPR On-Target Effects via Deep Learning](https://arxiv.org/html/2409.05938v1)* –∞–≤—Ç–æ—Ä—ã —Ä–µ—à–∞—é—Ç –∑–∞–¥–∞—á—É —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–∞–ø—Ä–∞–≤–ª—è—é—â–∏—Ö –†–ù–ö (sgRNA) –¥–ª—è CRISPR-Cas13d, –∫–æ—Ç–æ—Ä—ã–π –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç Cas9, —Ä–∞–∑—Ä–µ–∑–∞–µ—Ç –†–ù–ö, –∞ –Ω–µ –î–ù–ö. –ê–≤—Ç–æ—Ä—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—Ç DeepFM-Crispr, –≥–ª—É–±–æ–∫—É—é –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–≤—É—é –º–æ–¥–µ–ª—å, –∫–æ—Ç–æ—Ä–∞—è –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç on-target –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å (–Ω–∞—Å–∫–æ–ª—å–∫–æ —Ö–æ—Ä–æ—à–æ sgRNA —Å–≤—è–∑—ã–≤–∞–µ—Ç—Å—è —Å –º–∏—à–µ–Ω—å—é) –∏ off-target —ç—Ñ—Ñ–µ–∫—Ç—ã (–Ω–µ–ø—Ä–µ–¥–Ω–∞–º–µ—Ä–µ–Ω–Ω—ã–µ —Ä–∞–∑—Ä–µ–∑—ã). –ú–æ–¥–µ–ª—å –∏—Å–ø–æ–ª—å–∑—É–µ—Ç LLM RNA-FM –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è —ç–≤–æ–ª—é—Ü–∏–æ–Ω–Ω–æ-—Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö —ç–º–±–µ–¥–¥–∏–Ω–≥–æ–≤ sgRNA, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞—Ç–µ–º –æ–±—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç—Å—è —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–µ—Ä–æ–º, –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ DeepFM-Crispr –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–µ –º–æ–¥–µ–ª–∏ –ø–æ —Ç–æ—á–Ω–æ—Å—Ç–∏ –∏ –Ω–∞–¥—ë–∂–Ω–æ—Å—Ç–∏ –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–π.

–ú–æ–¥–µ–ª—å RNA-FM –±—ã–ª–∞ –≤–∑—è—Ç–∞ –∏–∑ *[J. Chen et al. (2022) Interpretable RNA Foundation Model from Unannotated Data for Highly Accurate RNA Structure and Function Predictions](https://arxiv.org/pdf/2204.00300)*

- –ê—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä–∞: –û—Å–Ω–æ–≤–∞–Ω–∞ –Ω–∞ BERT-–ø–æ–¥–æ–±–Ω–æ–π —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–µ—Ä–Ω–æ–π –º–æ–¥–µ–ª–∏ —Å 12 —Å–ª–æ—è–º–∏ —ç–Ω–∫–æ–¥–µ—Ä–æ–≤.
- –î–∞–Ω–Ω—ã–µ –¥–ª—è –æ–±—É—á–µ–Ω–∏—è: 23 –º–∏–ª–ª–∏–æ–Ω–∞ –Ω–µ–∫–æ–¥–∏—Ä—É—é—â–∏—Ö –†–ù–ö –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π –∏–∑ –±–∞–∑—ã RNAcentral.
- –ú–µ—Ç–æ–¥ –æ–±—É—á–µ–Ω–∏—è: self-supervised learning —Å –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ–º –∑–∞–º–∞—Å–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω—É–∫–ª–µ–æ—Ç–∏–¥–æ–≤ (Masked Language Modeling, MLM).
- –†–∞–∑–º–µ—Ä —ç–º–±–µ–¥–¥–∏–Ω–≥–æ–≤: –ö–∞–∂–¥–∞—è –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å –†–ù–ö –ø—Ä–µ–≤—Ä–∞—â–∞–µ—Ç—Å—è –≤ –º–∞—Ç—Ä–∏—Ü—É —Ä–∞–∑–º–µ—Ä–æ–º ùêø √ó 640, –≥–¥–µ ùêø ‚Äî –¥–ª–∏–Ω–∞ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏.

## CHOOSER framework

[W. Li et al. (2024) Discovering CRISPR-Cas system with self-processing pre-crRNA capability by foundation models](https://www.nature.com/articles/s41467-024-54365-0)

–°—Ç–∞—Ç—å—è –ø–æ—Å–≤—è—â–µ–Ω–∞ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∏—é –∏ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞–Ω–Ω–æ—Ç–∞—Ü–∏–∏ CRISPR-Cas —Å–∏—Å—Ç–µ–º, –æ—Å–æ–±–µ–Ω–Ω–æ Cas12-–ø–æ–¥–æ–±–Ω—ã—Ö –±–µ–ª–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –æ–±—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å pre-crRNA. –≠—Ç–æ –≤–∞–∂–Ω–æ, –ø–æ—Å–∫–æ–ª—å–∫—É —Ç–∞–∫–∏–µ –±–µ–ª–∫–∏ –º–æ–≥—É—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–ø—Ä–æ—Å—Ç–∏—Ç—å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ CRISPR –¥–ª—è —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–º–∞.

–¢—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–µ –º–µ—Ç–æ–¥—ã –ø–æ–∏—Å–∫–∞ –Ω–æ–≤—ã—Ö Cas-–±–µ–ª–∫–æ–≤ –æ—Å–Ω–æ–≤–∞–Ω—ã –Ω–∞ —Å—Ö–æ–¥—Å—Ç–≤–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π, —á—Ç–æ –Ω–µ –≤—Å–µ–≥–¥–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –¥–ª—è –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∏—è —É–¥–∞–ª–µ–Ω–Ω—ã—Ö –≥–æ–º–æ–ª–æ–≥–æ–≤. –ê–≤—Ç–æ—Ä—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ CHOOSER (Cas Homolog Observing and Self-processing Screening) ‚Äî –Ω–æ–≤—ã–π AI-—Ñ—Ä–µ–π–º–≤–æ—Ä–∫, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –º–æ–¥–µ–ª–∏ –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ –Ω–∞ –±–æ–ª—å—à–∏—Ö —è–∑—ã–∫–æ–≤—ã—Ö –º–æ–¥–µ–ª—è—Ö (LLM), —á—Ç–æ–±—ã –∏–¥–µ–Ω—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å –∏ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ –∫–ª–∞—Å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å CRISPR-Cas —Å–∏—Å—Ç–µ–º—ã –±–µ–∑ –≤—ã—Ä–∞–≤–Ω–∏–≤–∞–Ω–∏—è –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π.

–í —Ö–æ–¥–µ —Ä–∞–±–æ—Ç—ã –±—ã–ª–æ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–æ 11 –Ω–æ–≤—ã—Ö –≥–æ–º–æ–ª–æ–≥–æ–≤ CasŒª, –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –æ–±–ª–∞–¥–∞—é—Ç —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é –∫ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–π –æ–±—Ä–∞–±–æ—Ç–∫–µ pre-crRNA. –û–¥–∏–Ω –∏–∑ –Ω–∏—Ö, EphcCasŒª, –ø—Ä–æ—à–µ–ª —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É, –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–≤—à—É—é –µ–≥–æ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å.

**–ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ LLM**
–í —Å—Ç–∞—Ç—å–µ –±–æ–ª—å—à–∏–µ —è–∑—ã–∫–æ–≤—ã–µ –º–æ–¥–µ–ª–∏ (LLM), –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ **ESM-2**, –ø—Ä–∏–º–µ–Ω—è–ª–∏—Å—å –¥–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è –∏ –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏–∏ –Ω–æ–≤—ã—Ö Cas-–±–µ–ª–∫–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö –∫ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–π –æ–±—Ä–∞–±–æ—Ç–∫–µ pre-crRNA. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏–ª–æ –æ–±–æ–π—Ç–∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –º–µ—Ç–æ–¥–æ–≤, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞ –≤—ã—Ä–∞–≤–Ω–∏–≤–∞–Ω–∏–∏ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π.

**–û—Å–Ω–æ–≤–Ω—ã–µ –∑–∞–¥–∞—á–∏, —Ä–µ—à–∞–µ–º—ã–µ —Å –ø–æ–º–æ—â—å—é LLM:**

1. –û–±–Ω–∞—Ä—É–∂–µ–Ω–∏–µ –Ω–æ–≤—ã—Ö Cas-–≥–æ–º–æ–ª–æ–≥–æ–≤:

    - –î–ª—è —ç—Ç–æ–≥–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞—Å—å ESM-2 (pretrained protein LLM), –∫–æ—Ç–æ—Ä–∞—è –±—ã–ª–∞ –¥–æ–æ–±—É—á–µ–Ω–∞ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö –ø—Ä–æ–∫–∞—Ä–∏–æ—Ç–∏—á–µ—Å–∫–∏—Ö Cas-–±–µ–ª–∫–æ–≤.
    - –ü–æ—Å–ª–µ –¥–æ–æ–±—É—á–µ–Ω–∏—è –º–æ–¥–µ–ª—å —Å–º–æ–≥–ª–∞ –æ–±–Ω–∞—Ä—É–∂–∏–≤–∞—Ç—å Cas9, Cas12, Cas13 –±–µ–ª–∫–∏, –≤–∫–ª—é—á–∞—è —Ä–µ–¥–∫–∏–µ –ø–æ–¥—Ç–∏–ø—ã.

2. –§—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏—è Cas12-–±–µ–ª–∫–æ–≤:

    - –î–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ Cas12 –∫ —Å–∞–º–æ–ø—Ä–æ—Ü–µ—Å—Å–∏–Ω–≥—É pre-crRNA –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å —ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –∏–∑ –ø—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω—ã—Ö —Å–ª–æ–µ–≤ –º–æ–¥–µ–ª–∏ ESM-2.
    - –í —Ö–æ–¥–µ —Ç–µ—Å—Ç–æ–≤ —ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –∏–∑ ESM-2 –æ–∫–∞–∑–∞–ª–∏—Å—å –ª—É—á—à–µ, —á–µ–º –º–µ—Ç–æ–¥—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö (AlphaFold2, RoseTTAfold2).

3. –§–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–∏–π –∞–Ω–∞–ª–∏–∑ –Ω–∞–π–¥–µ–Ω–Ω—ã—Ö –±–µ–ª–∫–æ–≤:
    - –ê–≤—Ç–æ—Ä—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ LLM-—ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –¥–ª—è –∞–Ω–∞–ª–∏–∑–∞ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã Cas12.
    - –ú–æ–¥–µ–ª—å —Å–º–æ–≥–ª–∞ —Ä–∞–∑–¥–µ–ª—è—Ç—å –±–µ–ª–∫–∏ —Å —Ä–∞–∑–Ω—ã–º–∏ —Ñ—É–Ω–∫—Ü–∏—è–º–∏, –æ—Å–Ω–æ–≤—ã–≤–∞—è—Å—å —Ç–æ–ª—å–∫–æ –Ω–∞ –∏—Ö –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—è—Ö.

**–ì–¥–µ –ø—Ä–æ–≤–µ—Ä—è–ª–∞—Å—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å?**
- –û–±–Ω–∞—Ä—É–∂–µ–Ω–∏–µ Cas-–±–µ–ª–∫–æ–≤ —Å—Ä–µ–¥–∏ –º–∏–∫—Ä–æ–±–Ω—ã—Ö –≥–µ–Ω–æ–º–æ–≤ (–∫–∞–∫ –ø—Ä–æ–∫–∞—Ä–∏–æ—Ç–∏—á–µ—Å–∫–∏—Ö, —Ç–∞–∫ –∏ –≤–∏—Ä—É—Å–Ω—ã—Ö).
- –§—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞—Ç–µ–ª—å–Ω–∞—è –º–æ–¥–µ–ª—å —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ Cas12 –∫ —Å–∞–º–æ–ø—Ä–æ—Ü–µ—Å—Å–∏–Ω–≥—É.
- –°—Ä–∞–≤–Ω–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Å —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–º–∏ –º–µ—Ç–æ–¥–∞–º–∏, —Ç–∞–∫–∏–º–∏ –∫–∞–∫ –≥–ª—É–±–æ–∫–∏–µ —Å–≤–µ—Ä—Ç–æ—á–Ω—ã–µ —Å–µ—Ç–∏ (CNN), BiLSTM –∏ —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –º–µ—Ç–æ–¥—ã.

**–ö–ª—é—á–µ–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã**
- LLM-—ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –∏–∑ ESM-2 –ø—Ä–µ–≤–∑–æ—à–ª–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–µ –º–µ—Ç–æ–¥—ã –¥–ª—è –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∏—è CRISPR-Cas —Å–∏—Å—Ç–µ–º.
- –û–±–Ω–∞—Ä—É–∂–µ–Ω—ã 11 –Ω–æ–≤—ã—Ö –≥–æ–º–æ–ª–æ–≥–æ–≤ CasŒª, –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω—ã –∫–∞–∫ –∞–∫—Ç–∏–≤–Ω—ã–µ.
- –û–¥–∏–Ω –∏–∑ –Ω–∏—Ö, EphcCasŒª, –±—ã–ª –ø—Ä–æ–≤–µ—Ä–µ–Ω —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ, –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–≤ —Å–≤–æ—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ —Ä–∞–∑—Ä–µ–∑–µ pre-crRNA –ø—Ä–æ—Ü–µ—Å—Å–∏–Ω–≥–∞, —á—Ç–æ –¥–µ–ª–∞–µ—Ç –µ–≥–æ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–º –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–º –¥–ª—è —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–º–∞.

## GPT-3.5 and ProtT5 for embeddings

[K. M√§rtens et al. (2024) Enhancing generative perturbation models with LLM-informed gene embeddings](https://openreview.net/forum?id=eb3ndUlkt4)

–°—Ç–∞—Ç—å—è –ø–æ—Å–≤—è—â–µ–Ω–∞ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—é –æ—Ç–≤–µ—Ç–∞ –∫–ª–µ—Ç–æ–∫ –Ω–∞ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–µ –º—É—Ç–∞—Ü–∏–∏ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã—Ö –º–æ–¥–µ–ª–µ–π. –¶–µ–ª—å ‚Äî –ø—Ä–µ–¥—Å–∫–∞–∑–∞—Ç—å –≤–ª–∏—è–Ω–∏–µ –Ω–æ–∫–∞—É—Ç–æ–≤ (–≤—ã–∫–ª—é—á–µ–Ω–∏–π) –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≥–µ–Ω–æ–≤ –Ω–∞ —ç–∫—Å–ø—Ä–µ—Å—Å–∏—é –¥—Ä—É–≥–∏—Ö –≥–µ–Ω–æ–≤, —á—Ç–æ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω–æ –¥–ª—è –ø–æ–Ω–∏–º–∞–Ω–∏—è —Ä–µ–≥—É–ª—è—Ü–∏–∏ –≥–µ–Ω–æ–≤, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤.

**–û—Å–Ω–æ–≤–Ω–∞—è –ø—Ä–æ–±–ª–µ–º–∞:** –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –º–æ–¥–µ–ª–µ–π (–Ω–∞–ø—Ä–∏–º–µ—Ä, Compositional Perturbation Autoencoder (CPA) –∏ sVAE+) —Ö–æ—Ä–æ—à–æ —Ä–∞–±–æ—Ç–∞—é—Ç —Ç–æ–ª—å–∫–æ –Ω–∞ –∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –º—É—Ç–∞—Ü–∏—è—Ö –∏ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—Ç—å –≤–ª–∏—è–Ω–∏–µ –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω—ã—Ö —Ä–∞–Ω–µ–µ –º—É—Ç–∞—Ü–∏–π.

**–†–µ—à–µ–Ω–∏–µ:** –ê–≤—Ç–æ—Ä—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –Ω–æ–≤—ã–π –º–µ—Ç–æ–¥, –∏—Å–ø–æ–ª—å–∑—É—é—â–∏–π —ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –≥–µ–Ω–æ–≤, –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ –∏–∑ –±–æ–ª—å—à–∏—Ö —è–∑—ã–∫–æ–≤—ã—Ö –º–æ–¥–µ–ª–µ–π (LLM). –≠—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –æ–±—É—á–∏—Ç—å –≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã–µ –º–æ–¥–µ–ª–∏, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—Ç—å –≤–ª–∏—è–Ω–∏–µ –¥–∞–∂–µ —Ç–µ—Ö –º—É—Ç–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ –±—ã–ª–æ –≤ –æ–±—É—á–∞—é—â–∏—Ö –¥–∞–Ω–Ω—ã—Ö.

**–ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ LLM**

–ê–≤—Ç–æ—Ä—ã –ø—Ä–∏–º–µ–Ω–∏–ª–∏ —ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –≥–µ–Ω–æ–≤, –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ –∏–∑ LLM, —á—Ç–æ–±—ã –æ–±–æ–≥–∞—Ç–∏—Ç—å –≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—É—é –º–æ–¥–µ–ª—å –∑–Ω–∞–Ω–∏—è–º–∏ –æ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º –∫–æ–Ω—Ç–µ–∫—Å—Ç–µ.
–ò—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å –¥–≤–∞ —Ç–∏–ø–∞ —ç–º–±–µ–¥–¥–∏–Ω–≥–æ–≤:
- *–¢–µ–∫—Å—Ç–æ–≤—ã–µ —ç–º–±–µ–¥–¥–∏–Ω–≥–∏* ‚Äî –ø–æ–ª—É—á–µ–Ω—ã –∏–∑ GPT-3.5, –∏—Å–ø–æ–ª—å–∑—É—è –æ–ø–∏—Å–∞–Ω–∏—è –≥–µ–Ω–æ–≤ –∏–∑ –±–∞–∑—ã –¥–∞–Ω–Ω—ã—Ö NCBI.
- *–ë–µ–ª–∫–æ–≤—ã–µ —ç–º–±–µ–¥–¥–∏–Ω–≥–∏*‚Äî –ø–æ–ª—É—á–µ–Ω—ã –∏–∑ –º–æ–¥–µ–ª–∏ ProtT5, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞–µ—Ç —Å–≤–æ–π—Å—Ç–≤–∞ –±–µ–ª–∫–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏—Ö –∞–º–∏–Ω–æ–∫–∏—Å–ª–æ—Ç–Ω—ã—Ö –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π.

LLM-—ç–º–±–µ–¥–¥–∏–Ω–≥–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å –≤ –ì–∞—É—Å—Å–æ–≤—ã—Ö –ø—Ä–æ—Ü–µ—Å—Å–∞—Ö (Gaussian Processes, GP) –¥–ª—è –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Ç–≤–µ—Ç–∞ –∫–ª–µ—Ç–æ–∫ –Ω–∞ –Ω–æ–∫–∞—É—Ç –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–≥–æ –≥–µ–Ω–∞.

**–ö–∞–∫–∏–µ –∑–∞–¥–∞—á–∏ –ø—Ä–æ–≤–µ—Ä—è–ª–∏?**
- –î–≤–∞ —Ç–∏–ø–∞ –∫–ª–µ—Ç–æ—á–Ω—ã—Ö –ª–∏–Ω–∏–π (K562 –∏ RPE1) ‚Äî –ø—Ä–æ–≤–µ—Ä—è–ª–∏, –Ω–∞—Å–∫–æ–ª—å–∫–æ —Ç–æ—á–Ω–æ –º–æ–¥–µ–ª—å –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞–µ—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è —ç–∫—Å–ø—Ä–µ—Å—Å–∏–∏ –≥–µ–Ω–æ–≤ –ø–æ—Å–ª–µ –º—É—Ç–∞—Ü–∏–∏.
- –°—Ä–∞–≤–Ω–µ–Ω–∏–µ —Å –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–º–∏ –º–µ—Ç–æ–¥–∞–º–∏ (CPA, GEARS) ‚Äî –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ LLM + GP –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–ª—É—á—à–∞—é—Ç —Ç–æ—á–Ω–æ—Å—Ç—å –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–π.
–ü—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ –æ—Ç–≤–µ—Ç–∞ –Ω–∞ –Ω–æ–≤—ã–µ –º—É—Ç–∞—Ü–∏–∏ ‚Äî –º–æ–¥–µ–ª—å —É—Å–ø–µ—à–Ω–æ –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞–ª–∞ —ç—Ñ—Ñ–µ–∫—Ç—ã –Ω–æ–∫–∞—É—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –±—ã–ª–∏ –≤ –æ–±—É—á–∞—é—â–µ–π –≤—ã–±–æ—Ä–∫–µ.

## Not only for CRISPR

–û –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ LLM –¥–ª—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –≤ —Å—Ñ–µ—Ä–µ –º–∏–∫—Ä–æ–±–∏–æ–º–∞ –∏ –º–µ—Ç–∞–≥–µ–Ω–æ–º–∏–∫–∏ –º–æ–∂–Ω–æ –ø—Ä–æ—á–∏—Ç–∞—Ç—å –≤ —Å—Ç–∞—Ç—å–µ [B. Yan et al. (2025) Recent advances in deep learning and language models for studying the microbiome](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2024.1494474/full). –û—Å–Ω–æ–≤–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∏ –ø—Ä–∏–º–µ—Ä—ã –º–æ–¥–µ–ª–µ–π:

| –ó–∞–¥–∞—á–∞ | –ò—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ –º–æ–¥–µ–ª–∏ | –û–ø–∏—Å–∞–Ω–∏–µ |
|----------|----------|----------|
| –ü—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –∏ —Ñ—É–Ω–∫—Ü–∏–π –±–µ–ª–∫–æ–≤	| ESM-2, ProtBERT, ProGen, ProtGPT2	| –ò—Å–ø–æ–ª—å–∑—É—é—Ç —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–µ—Ä—ã –¥–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –±–µ–ª–∫–æ–≤ –∏ –∏—Ö —Ñ—É–Ω–∫—Ü–∏–π. |
| –ì–µ–Ω–µ—Ä–∞—Ü–∏—è –Ω–æ–≤—ã—Ö –±–µ–ª–∫–æ–≤	| ProGen, ProtGPT2 |	–ê–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ GPT-–º–æ–¥–µ–ª–∏, –≥–µ–Ω–µ—Ä–∏—Ä—É—é—â–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–µ –±–µ–ª–∫–æ–≤—ã–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. |
| –ü—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π –≤–∏—Ä—É—Å–æ–≤ –∏ –±–∞–∫—Ç–µ—Ä–∏–π	| ViraLM (–º–æ–¥–∏—Ñ–∏–∫–∞—Ü–∏—è DNABERT-2) |	–û–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π –≤–∏—Ä—É—Å–æ–≤ —Å —Ö–æ–∑—è–µ–≤–∞–º–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –≥–µ–Ω–æ–º–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö. |
| –í—ã–¥–µ–ª–µ–Ω–∏–µ –±–∏–æ—Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏—Ö –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –∫–ª–∞—Å—Ç–µ—Ä–æ–≤ (BGCs)	| BGC-Prophet, DeepBGC	| –í—ã—è–≤–ª–µ–Ω–∏–µ –∫–ª–∞—Å—Ç–µ—Ä–æ–≤ –≥–µ–Ω–æ–≤, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞ —Å–∏–Ω—Ç–µ–∑ –≤—Ç–æ—Ä–∏—á–Ω—ã—Ö –º–µ—Ç–∞–±–æ–ª–∏—Ç–æ–≤. |
| –ö–æ–Ω—Ç–µ–∫—Å—Ç–Ω–æ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –≥–µ–Ω–æ–≤ –≤ –º–∏–∫—Ä–æ–±–∏–æ–º–∞—Ö	| gLM, FGBERT |	–û–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏ –≥–µ–Ω–æ–≤ –≤ –≥–µ–Ω–æ–º–Ω–æ–º –∫–æ–Ω—Ç–µ–∫—Å—Ç–µ. |
| –ê–Ω–Ω–æ—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –≤–∏—Ä—É—Å–Ω—ã—Ö –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π	| ViraLM, Flamholz et al. (2024) | –ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ PLM –¥–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è —Ñ—É–Ω–∫—Ü–∏–π –≤–∏—Ä—É—Å–Ω—ã—Ö –±–µ–ª–∫–æ–≤. |


–°—Ç–∞—Ç—å—è [S. Jiang, D. Yi (2024) Deep Learning-Based Self-Adaptive Evolution of Enzymes](https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0044-1788317.pdf) —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç —ç–≤–æ–ª—é—Ü–∏—é —Ñ–µ—Ä–º–µ–Ω—Ç–æ–≤ —Å –ø–æ–º–æ—â—å—é –≥–ª—É–±–æ–∫–æ–≥–æ –æ–±—É—á–µ–Ω–∏—è (DL). –≠—Ç–æ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è –∫ –±–∏–æ–∫–∞—Ç–∞–ª–∏–∑—É –∏ –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ, –≥–¥–µ —Ñ–µ—Ä–º–µ–Ω—Ç—ã –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ö–∏–º–∏—á–µ—Å–∫–∏—Ö —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π —Å –≤—ã—Å–æ–∫–æ–π —Ö–∏—Ä–∞–ª—å–Ω–æ–π –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π —Å–µ–ª–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é. –§–µ—Ä–º–µ–Ω—Ç—ã –≤ –¥–∏–∫–æ–π –ø—Ä–∏—Ä–æ–¥–µ —ç–≤–æ–ª—é—Ü–∏–æ–Ω–∏—Ä–æ–≤–∞–ª–∏ –¥–ª—è —Ä–∞–±–æ—Ç—ã —Å –ø—Ä–∏—Ä–æ–¥–Ω—ã–º–∏ —Å—É–±—Å—Ç—Ä–∞—Ç–∞–º–∏, –Ω–æ —á–∞—Å—Ç–æ –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã –¥–ª—è —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –î–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –∏—Ö –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç–∏ —Ç—Ä–µ–±—É–µ—Ç—Å—è –±–µ–ª–∫–æ–≤–∞—è –∏–Ω–∂–µ–Ω–µ—Ä–∏—è.

| –ó–∞–¥–∞—á–∞ | –ò—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ –º–æ–¥–µ–ª–∏ | –û–ø–∏—Å–∞–Ω–∏–µ |
|--------|----------------------|----------|
| –ü—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –±–µ–ª–∫–æ–≤ | AlphaFold2, ESMFold | DL-–º–æ–¥–µ–ª–∏, –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—é—â–∏–µ 3D-—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –±–µ–ª–∫–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π –∞–º–∏–Ω–æ–∫–∏—Å–ª–æ—Ç. |
| –ò–∑—É—á–µ–Ω–∏–µ —Å–≤—è–∑–∏ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏ —Ñ—É–Ω–∫—Ü–∏–∏ –±–µ–ª–∫–æ–≤ | MLP, RNN, CNN | –û–ø—Ä–µ–¥–µ–ª—è—é—Ç, –∫–∞–∫–∏–µ –º—É—Ç–∞—Ü–∏–∏ —É–ª—É—á—à–∞—é—Ç –∫–∞—Ç–∞–ª–∏–∑, —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –∏ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ñ–µ—Ä–º–µ–Ω—Ç–æ–≤. |
| –ì–µ–Ω–µ—Ä–∞—Ü–∏—è –Ω–æ–≤—ã—Ö –±–µ–ª–∫–æ–≤ –∏ –º—É—Ç–∞—Ü–∏–π | VAE, GAN, ProGen, ProT-VAE | –ì–µ–Ω–µ—Ä–∏—Ä—É—é—Ç –Ω–æ–≤—ã–µ –±–µ–ª–∫–æ–≤—ã–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Å –∑–∞–¥–∞–Ω–Ω—ã–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏, —Å–æ–∑–¥–∞–≤–∞—è –≤–∏—Ä—Ç—É–∞–ª—å–Ω—ã–µ –±–∏–±–ª–∏–æ—Ç–µ–∫–∏ –º—É—Ç–∞–Ω—Ç–æ–≤. |
| –û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è –∫–∞—Ç–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ñ–µ—Ä–º–µ–Ω—Ç–æ–≤ | DLKcat, GNN, CNN | –ü—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—é—Ç —Å–∫–æ—Ä–æ—Å—Ç—å —Ñ–µ—Ä–º–µ–Ω—Ç–∞—Ç–∏–≤–Ω—ã—Ö —Ä–µ–∞–∫—Ü–∏–π (Kcat) –∏ –ø–æ–¥–±–∏—Ä–∞—é—Ç –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–µ –º—É—Ç–∞—Ü–∏–∏ –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. |
| –í—ã—è–≤–ª–µ–Ω–∏–µ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —É—á–∞—Å—Ç–∫–æ–≤ –±–µ–ª–∫–æ–≤ | GNN, 3D-CNN, SE(3) Transformer | –ê–Ω–∞–ª–∏–∑–∏—Ä—É—é—Ç —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –¥–ª—è –ø–æ–∏—Å–∫–∞ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ –≤–∞–∂–Ω—ã—Ö –∞–º–∏–Ω–æ–∫–∏—Å–ª–æ—Ç–Ω—ã—Ö –æ—Å—Ç–∞—Ç–∫–æ–≤. |
| –ü—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ –º—É—Ç–∞—Ü–∏–π –≤ –º–µ—Ç–∞–ª–ª-—Å–≤—è–∑—ã–≤–∞—é—â–∏—Ö –±–µ–ª–∫–∞—Ö | MCCNN | –û–ø—Ä–µ–¥–µ–ª—è–µ—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ –º—É—Ç–∞—Ü–∏–∏, –≤–ª–∏—è—é—â–∏–µ –Ω–∞ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –º–µ—Ç–∞–ª–ª-–∑–∞–≤–∏—Å–∏–º—ã—Ö —Ñ–µ—Ä–º–µ–Ω—Ç–æ–≤. |
| –£–ª—É—á—à–µ–Ω–∏–µ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç–∏ –±–µ–ª–∫–æ–≤ | LM-GVP, BiLSTM, ECNet | DL-–º–æ–¥–µ–ª–∏, –∏—Å–ø–æ–ª—å–∑—É—é—â–∏–µ —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–Ω–æ–µ –æ–±—É—á–µ–Ω–∏–µ, –¥–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è –≤–ª–∏—è–Ω–∏—è –º—É—Ç–∞—Ü–∏–π –Ω–∞ —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å –±–µ–ª–∫–æ–≤. |
| –ê–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –ø—Ä–æ–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ —Ñ–µ—Ä–º–µ–Ω—Ç–æ–≤ | ProteinGAN, UniRep, ProtTrans | –°–æ–∑–¥–∞—é—Ç –±–µ–ª–∫–∏ —Å –∂–µ–ª–∞–µ–º—ã–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏, –æ–±—É—á–∞—è—Å—å –Ω–∞ –º–∏–ª–ª–∏–æ–Ω–∞—Ö –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π. |


# The use of on-target mismatched gRNAs

## ExsgRNA



## Prime editing

–ö—Ä–∞—Ç–∫–æ –æ –º–µ—Ç–æ–¥–µ –Ω–∞ —Ä—É—Å—Å–∫–æ–º: [–ù–æ–≤—ã–π –º–µ—Ç–æ–¥ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–º–∞ –æ–∫–∞–∑–∞–ª—Å—è —Ç–æ—á–Ω–µ–µ –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–æ–≥–æ CRISPR/Cas9 | N+1](https://nplus1.ru/news/2019/10/21/prime-editing)

–ú–µ—Ç–æ–¥ –ø—Ä–∞–π–º–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–º–∞ (prime editing) ‚Äî –º–æ–¥–∏—Ñ–∏–∫–∞—Ü–∏—è —Å–∏—Å—Ç–µ–º—ã CRISPR-Cas9, –ø–æ–∑–≤–æ–ª—è—é—â–∞—è –≤–Ω–æ—Å–∏—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏—è –±–µ–∑ –¥–≤—É—Ö—Ü–µ–ø–æ—á–µ—á–Ω–æ–≥–æ —Ä–∞–∑—Ä—ã–≤–∞. –ú–µ—Ç–æ–¥ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∫–∞—Ç–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏ –æ—Å–ª–∞–±–ª–µ–Ω–Ω—É—é –Ω–∏–∫–∞–∑—É Cas9, —Å—à–∏—Ç—É—é —Å –æ–±—Ä–∞—Ç–Ω–æ–π —Ç—Ä–∞–Ω—Å–∫—Ä–∏–ø—Ç–∞–∑–æ–π. (*[PCR News](https://pcr.news/novosti/dvoynoe-praymirovannoe-redaktirovanie-genoma-rabotaet-akkuratnee-crispr-cas9)*)

D–º–µ—Å—Ç–æ –Ω–∞–ø—Ä–∞–≤–ª—è—é—â–µ–π –†–ù–ö, –∫–æ—Ç–æ—Ä—É—é –∏—Å–ø–æ–ª—å–∑—É–µ—Ç CRISPR/Cas –¥–ª—è –Ω–∞–≤–µ–¥–µ–Ω–∏—è –Ω–∞ —Ü–µ–ª—å, –≤ –Ω–µ–µ –≤—Ö–æ–¥–∏—Ç —É–¥–ª–∏–Ω–µ–Ω–Ω–∞—è –≥–∏–¥–æ–≤–∞—è –†–ù–ö –¥–ª—è –ø—Ä–∞–π–º–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è (prime editing extended guide RNA, pegRNA, –ø—Ä–≥–†–ù–ö). –≠—Ç–∞ –†–ù–ö –≤—ã–ø–æ–ª–Ω—è–µ—Ç —Å—Ä–∞–∑—É –¥–≤–µ —Ñ—É–Ω–∫—Ü–∏–∏: –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –æ–±–ª–∞—Å—Ç—å, –≥–¥–µ –ø—Ä–æ–π–¥–µ—Ç —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ, –∏ –Ω–µ—Å–µ—Ç –≤ —Å–µ–±–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é, –∫–æ—Ç–æ—Ä—É—é –Ω—É–∂–Ω–æ ¬´–≤–ø–∏—Å–∞—Ç—å¬ª –≤ –≥–µ–Ω.

<img src="./images/prime_editing_components.png" style="width: 350px; height: 350px;">

*Components of prime editing* ([Wikipedia](https://en.wikipedia.org/wiki/Prime_editing))

–ú–µ—Ö–∞–Ω–∏–∑–º —Ä–∞–±–æ—Ç—ã –Ω–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –≤—ã–≥–ª—è–¥–∏—Ç —Å–ª–µ–¥—É—é—â–∏–º –æ–±—Ä–∞–∑–æ–º:

1. –ù–∞ –Ω–∏—Ç—å –î–ù–ö —Å–∞–¥–∏—Ç—Å—è –∏–∑–º–µ–Ω–µ–Ω–Ω—ã–π —Ñ–µ—Ä–º–µ–Ω—Ç Cas9, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞—Å–ø–ª–µ—Ç–∞–µ—Ç –¥—É–ø–ª–µ–∫—Å –Ω–∞ –¥–≤–µ –æ—Ç–¥–µ–ª—å–Ω—ã–µ —Ü–µ–ø–∏.
2. –ü—Ä–≥–†–ù–ö ¬´–Ω–∞–≤–æ–¥–∏—Ç—Å—è¬ª –Ω–∞ —É—á–∞—Å—Ç–æ–∫ –î–ù–ö, —Ç–æ –µ—Å—Ç—å –ø—Ä–∏–ª–∏–ø–∞–µ—Ç –∫ –æ–¥–Ω–æ–π –∏–∑ –Ω–∏—Ç–µ–π, –∑–∞—â–∏—â–∞—è –µ–µ. –ù–∞ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–ª–æ–∂–Ω–æ–π –Ω–∏—Ç–∏ Cas9 –≤–Ω–æ—Å–∏—Ç –æ–¥–Ω–æ—Ü–µ–ø–æ—á–µ—á–Ω—ã–π —Ä–∞–∑—Ä–µ–∑.
3. –î—Ä—É–≥–∏–º —Å–≤–æ–∏–º –∫–æ–Ω—Ü–æ–º –ø—Ä–≥–†–ù–ö –ø—Ä–∏–ª–∏–ø–∞–µ—Ç –∫ —Ä–∞–∑—Ä–µ–∑–∞–Ω–Ω–æ–π –Ω–∏—Ç–∏.
4. –ö –±–µ–ª–∫—É Cas9 –ø—Ä–∏—Å–æ–µ–¥–∏–Ω–µ–Ω –¥—Ä—É–≥–æ–π —Ñ–µ—Ä–º–µ–Ω—Ç ‚Äî –æ–±—Ä–∞—Ç–Ω–∞—è —Ç—Ä–∞—Å–Ω–∫—Ä–∏–ø—Ç–∞–∑–∞. –û–Ω–∞ —Å—Ç—Ä–æ–∏—Ç –î–ù–ö –Ω–∞ –æ—Å–Ω–æ–≤–µ –ø—Ä–≥-–†–ù–ö, —Ç–µ–º —Å–∞–º—ã–º ¬´–ø–µ—Ä–µ–ø–∏—Å—ã–≤–∞—è¬ª –≥–µ–Ω –∑–∞–Ω–æ–≤–æ.
5. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –ø–æ–ª—É—á–∞—é—Ç—Å—è –¥–≤–µ –≤–µ—Ä—Å–∏–∏ –æ–¥–Ω–æ–≥–æ –º–µ—Å—Ç–∞ –î–ù–ö: —Å—Ç–∞—Ä–∞—è –∏ –Ω–æ–≤–∞—è. –û–¥–Ω—É –∏–∑ –Ω–∏—Ö —Ä–∞–∑—Ä—É—à–∞—é—Ç –≤–Ω—É—Ç—Ä–∏–∫–ª–µ—Ç–æ—á–Ω—ã–µ –Ω—É–∫–ª–µ–∞–∑—ã, –∏ –Ω–µ—Ä–µ–¥–∫–æ —ç—Ç–æ –æ–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è —Å—Ç–∞—Ä–∞—è.
6. –ù–æ–≤—É—é –≤–µ—Ä—Å–∏—é –±–µ–ª–∫–∏ —Ä–µ–ø–∞—Ä–∞—Ü–∏–∏ –î–ù–ö ¬´–≤—à–∏–≤–∞—é—Ç¬ª –Ω–∞ –º–µ—Å—Ç–æ. –ü—Ä–∏ —ç—Ç–æ–º –Ω–æ–≤–∞—è —Ü–µ–ø—å –î–ù–ö –∏ –∫–æ–º–ø–ª–µ–º–µ–Ω—Ç–∞—Ä–Ω–∞—è –µ–π –≤—Ç–æ—Ä–∞—è —Ü–µ–ø—å –Ω–µ —Å–æ–≤–ø–∞–¥–∞—é—Ç, –∏ –±–µ–ª–∫–∏ —Ä–µ–ø–∞—Ä–∞—Ü–∏–∏ –¥–æ–ª–∂–Ω—ã –æ–¥–Ω—É –∏–∑ –Ω–∏—Ö —Ä–∞—Å—â–µ–ø–∏—Ç—å, –∞ –¥—Ä—É–≥—É—é ‚Äî –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –ø–æ –æ–±—Ä–∞–∑—Ü—É –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–ª–æ–∂–Ω–æ–π. –ï—Å–ª–∏ –¥–æ–±–∞–≤–∏—Ç—å –≤ —Å–∏—Å—Ç–µ–º—É –µ—â–µ –æ–¥–Ω—É –≥–∏–¥–æ–≤—É—é –†–ù–ö, –∫–æ—Ç–æ—Ä–∞—è –Ω–∞–≤–æ–¥–∏—Ç Cas9 –Ω–∞ ¬´–Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—É—é¬ª —Ü–µ–ø—å, —Ç–æ Cas9 –≤–Ω–æ—Å–∏—Ç –≤ –Ω–µ–µ —Ä–∞–∑—Ä—ã–≤—ã, –∏ –±–µ–ª–∫–∏ —Ä–µ–ø–∞—Ä–∞—Ü–∏–∏ –ø—Ä–∏–Ω–∏–º–∞—é—Ç –µ–µ –∑–∞ –æ—à–∏–±–æ—á–Ω—É—é. –í –∏—Ç–æ–≥–µ –ø–æ–ª—É—á–∞—é—Ç—Å—è –¥–≤–µ –∫–æ–ø–∏–∏ –Ω—É–∂–Ω–æ–π –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏.

<img src="./images/prime_editing_mechanism.png" style="width: 700px">

*Prime editing mechanism* ([Wikipedia](https://en.wikipedia.org/wiki/Prime_editing))

[J. Fei et. al. (2025) Mismatch prime editing gRNA increased efficiency and reduced indels](https://www.nature.com/articles/s41467-024-55578-z)

Some studies have reported that in certain circumstances, mismatches in the protospacer can also enhance the editing efficiency of Cas9 *[T. Zheng (2017) Profiling single-guide RNA specificity reveals a mismatch sensitive core sequence](https://www.nature.com/articles/srep40638)*